Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135875 · ClinicalTrials.gov registry record
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 130
- Enrollment target
NCT01135875 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 130 participants.
The verdict
NCT01135875 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
Interventions
- OTHER GBM Patients
- OTHER Normal Controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01135875
The ClinicalTrials.gov registry entry for NCT01135875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GBM Patients is the first listed.
NCT01135875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01135875 about?
NCT01135875 is a clinical study titled "Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients". The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
What is the current status of trial NCT01135875?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2009-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01135875?
The interventions under investigation include: GBM Patients (OTHER), Normal Controls (OTHER).
Who is sponsoring clinical trial NCT01135875?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.